Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Betamethasone

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

  • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).


    The EU Clinical Trials Register currently displays   44339   clinical trials with a EudraCT protocol, of which   7369   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    1  2  Next»
    Study title: A phase IV Multi-Center, Open-label Safety Study in pediatric Patients with atopic dermatitis, Treated with Diprolen AF Cream 0,05 % Twice daily, or diprosone ointment
    Active substance: BETAMETHASONE
    Study summary document link (including results):
    View full study record
    Document reference: 41911
    Study title: Anwendungsbeobachtung Cordes Beta Salbe
    Active substance: BETAMETHASONE
    Study summary document link (including results):
    View full study record
    Document reference: 41910
    Study title: Study of 0.01% betamethasone cream vs. placebo in steroid-sensitive dermatoses in children (1 to 12 years) – An incomplete, aborted study. Research Report 932-0460.
    Active substance: BETAMETHASONE
    Study summary document link (including results): betamethasone RR932-0460.pdf
    View full study record
    Document reference: 47778
    Study title: Study of 0.1% betamethasone cream vs placebo in steroid sensitive dermatoses in children (1 to 12 years) - an incomplete, aborted study.
    Active substance: BETAMETHASONE
    Study summary document link (including results):
    View full study record
    Document reference: 41912
    Study title: Evaluation of a new sequential treatment with an association of fusidic acid and two different steroids
    Active substance: BETAMETHASONE AND FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 41921
    Study title: Fucicort and Betnovate N in Various types of Infected Eczemas
    Active substance: BETAMETHASONE AND FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 41920
    Study title: Fucicort fatty cream in clinically infected atopic dermatitis
    Active substance: BETAMETHASONE AND FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 45094
    Study title: Fucicort fatty cream in clinically infected atopic dermatitis
    Active substance: BETAMETHASONE AND FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 41919
    Study title: Randomised controlled trial of short bursts of a potent topical cortico steroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. Thomas KS, Armstrong S, Avery A, Po ALW, O'Neill C, Young S, et aRandomised controlled trial of short bursts of a potent topical cortico steroid versus prolonged use of a mild preparation for children with mild or moderate atopic eczema. Thomas KS, Armstrong S, Avery A, Po ALW, O'Neill C, Young S, et a
    Active substance: BETAMETHASONE AND FUSIDIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 41922
    Study title: Wolf-Jurgensen, P. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial. 1979; 5: 779-784Wolf-Jurgensen, P. Efficacy of bufexamac cream versus betamethasone valerate cream in contact dermatitis: a double-blind trial. 1979; 5: 779-784
    Active substance: BUFEXAMAC
    Study summary document link (including results):
    View full study record
    Document reference: 23053
    Study title: Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Wright M, Butt Z, McIlwaine G, Fleck B. Br J Ophthalmol. 1997 Apr;81(4):299-301. Comparison of the efficacy of diclofenac and betamethasone following strabismus surgery. Wright M, Butt Z, McIlwaine G, Fleck B. Br J Ophthalmol. 1997 Apr;81(4):299-301.
    Active substance: DICLOPHENAC AND TOBRAMYCIN
    Study summary document link (including results):
    View full study record
    Document reference: 26090
    Study title: A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydroxycortisone creams in the treatment of eczema. Ashton et al. 1987 (The Journal of International Medical Research 15: 160-166) - Publication mentioned as part of CES on Desoximetasone Flubason - Sostens Ferrer F. - 09/1998 -A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydroxycortisone creams in the treatment of eczema. Ashton et al. 1987 (The Journal of International Medical Research 15: 160-166) - Publication mentioned as part of CES on Desoximetasone Flubason - Sostens Ferrer F. - 09/1998 -
    Active substance: DESOXYMETHASONE
    Study summary document link (including results):
    View full study record
    Document reference: 25680
    Study title: A double-blind controlled trial of betamethasone dipropionate 0.05% (Diproderm) in comparison with fluocinolone acetonide 0.025% (Synalar) in psoriasis and other steroid-responsive dermatoses.
    Active substance: FLUOROCINONIDE
    Study summary document link (including results):
    View full study record
    Document reference: 28253
    Study title: Khan, S. A. and Williamson, D. M. A double-blind comparison of 1% hydrocortisone plus 10% urea ('Alphaderm') and 0.1% betamethasone 17-valerate in the treatment of non-infective inflammatory dermatoses Curr.Med.Res.Opin. 1977;5:354-358.
    Active substance: HYDROCORTIZONE AND UREA
    Study summary document link (including results):
    View full study record
    Document reference: 29189
    Study title: Effects of prenatal exposure to betamethasone and indomethacin on the glomerular filtration rate in the preterm infant.
    Active substance: INDOMETHACIN
    Study summary document link (including results):
    View full study record
    Document reference: 29894
    Study title: Efficacy and safety of loratadina-betamethasone combination in the initial treatment of severe perennial allergic rhinitis in children
    Active substance: LARATADINE
    Study summary document link (including results):
    View full study record
    Document reference: 31019
    Study title: Efficacy and safety of loratadina-betamethasone combination in the initial treatment of severe perennial allergic rhinitis in children
    Active substance: LARATADINE
    Study summary document link (including results):
    View full study record
    Document reference: 31016
    Study title: Efficacy and safety of loratadina-betamethasone combination in the initial treatment of severe perennial allergic rhinitis in children
    Active substance: LORATADINE
    Study summary document link (including results):
    View full study record
    Document reference: 31466
    Study title: Multicentre open clinical trial, in parallel groups, on the value of Oleatum emollient oil in the treatment of atopic eczema with topical corticosteroid therapy (Betamethasone-17-Valerate).
    Active substance: LIQUID PARAFFIN
    Study summary document link (including results): Article 45_Ref_C0474_Final For Submission_27 Oct 2011.xlsx
    View full study record
    Document reference: 31286
    Study title: A double-blind multicentre parallel group study comparing HOE777 fatty ointment with betamethasone valerate 0,1% fatty ointment in patients with mild to severe atopic or eczematous contact dermatitis - M. Dietz et al. - 1982 (unpublished report) - Publication in Clinical Expert report : The topical Corticosteroid Prednicarbate - W. Schulz et al. - 10/ 1991
    Active substance: PREDNICARBATE
    Study summary document link (including results): Prednicarbate STUDY Dietz.xls
    View full study record
    Document reference: 34665
    1  2  Next»
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Sun Jun 01 19:57:44 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA